Molecular Characterization by Next-Generation Sequencing (NGS) of Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Immunotherapy

被引：0
作者：
Cruz Castellanos, P. [1 ]
Rosas Alonso, R. [1 ]
Ozaez, I. [1 ]
Hernandez, I. [1 ]
Losantos, I. [1 ]
Gutierrez Sainz, L. [1 ]
Higuera Gomez, O. [1 ]
Rodriguez Antolin, C. [1 ]
Esteban Rodriguez, I. [1 ]
Ibanez de Caceres, I. [1 ]
de Castro Carpeno, J. [1 ]
机构：
[1] Hosp Univ La Paz, IdiPAZ, Madrid, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期
关键词：
Non-small cell lung cancer; Next-Generation Sequencing (NGS); Immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP16.01-00
引用
收藏
页码：S558 / S558
页数：1
相关论文
共 50 条
  • [21] The utilization of next-generation sequencing to detect somatic mutations and predict clinical prognosis of Chinese non-small cell lung cancer patients
    Cao, Liming
    Long, Long
    Li, Min
    Yang, Huaping
    Deng, Pengbo
    Mao, Xinru
    Xiang, Jianxing
    Li, Bing
    Zhang, Tengfei
    Hu, Chengping
    ONCOTARGETS AND THERAPY, 2018, 11 : 2637 - 2646
  • [22] Genetic Profiling of Idiopathic Pulmonary Fibrosis Associated Non-Small Cell Lung Cancer by Targeted Next-Generation Sequencing
    Otsubo, K.
    Iwama, E.
    Tanaka, K.
    Shiraishi, Y.
    Yoneshima, Y.
    Inoue, H.
    Tagawa, T.
    Nakanishi, Y.
    Okamoto, I.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S953 - S953
  • [23] Immunotherapy for non-small cell lung cancer
    Vafadar, Sam
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2019, 32 (09): : 37 - 42
  • [24] Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer
    Wen, Shiwang
    Dai, Lei
    Wang, Lei
    Wang, Wenjian
    Wu, Duoguang
    Wang, Kefeng
    He, Zhanghai
    Wang, Aodi
    Chen, Hui
    Zhang, Peng
    Dong, Xiaowei
    Dong, Yu-An
    Wang, Kai
    Yao, Ming
    Wang, Minghui
    ONCOLOGIST, 2019, 24 (11) : E1070 - E1081
  • [25] Advancements in next-generation sequencing for diagnosis and treatment of non-small-cell lung cancer
    Ying-Qiang Lu
    Kai-Hua Lu
    慢性疾病与转化医学（英文）, 2017, 3 (01) : 1 - 7
  • [26] Predictive value of tumor mutation burden (TMB) with targeted next-generation sequencing in immuno-checkpoint inhibitors for non-small cell lung cancer (NSCLC)
    Ma, Xiaoting
    Zhang, Yujian
    Wang, Shan
    Yu, Jing
    JOURNAL OF CANCER, 2021, 12 (02): : 584 - 594
  • [27] Next-Generation Sequencing for Effective Detection of Various EGFR Exon 20 Insertions (E20ins) in Non-Small Cell Lung Cancer (NSCLC)
    Hwang, I.
    Kim, S.
    Chun, S.
    Yoon, S.
    Lee, D. H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S659 - S659
  • [28] Translation of next-generation sequencing (NGS) into molecular diagnostics
    Kotschote, Stefan
    Wagner, Carola
    Marschall, Christoph
    Mayer, Karin
    Hirv, Kaimo
    Kerick, Martin
    Timmermann, Bernd
    Klein, Harms-Georg
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2010, 34 (06): : 311 - 318
  • [29] Molecular characteristics and clinical outcomes of complex ALK rearrangements identified by next-generation sequencing in non-small cell lung cancers
    Peiyi Xia
    Lan Zhang
    Pan Li
    Enjie Liu
    Wencai Li
    Jianying Zhang
    Hui Li
    Xiaoxing Su
    Guozhong Jiang
    Journal of Translational Medicine, 19
  • [30] Molecular characteristics and clinical outcomes of complex ALK rearrangements identified by next-generation sequencing in non-small cell lung cancers
    Xia, Peiyi
    Zhang, Lan
    Li, Pan
    Liu, Enjie
    Li, Wencai
    Zhang, Jianying
    Li, Hui
    Su, Xiaoxing
    Jiang, Guozhong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
12345